Lindbrook Capital »

Arcturus Therapeutics Hldg I shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.3k 68 33.76
2023-12-31 $2.1k 68 31.53
2022-09-30 $0 15 0.00
2022-06-30 $0 14 0.00

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Golub Cap Bdc Cef (GBDC)
Apple Stock (AAPL)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Ishares Russell 1000 Value Etf Etf (IWD)
Amazon.com Stock (AMZN)
Powershares Qqq Tr Etf (QQQ)
Oaktree Specialty Lending Corp Cef (OCSL)
Vertex Pharmaceuticals In Stock (VRTX)
Broadcom Stock (AVGO)

View all positions for Lindbrook Capital

Top funds holding Arcturus Therapeutics Hldg I

Federated Investors
BlackRock
ARK Investment Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Dimensional Fund Advisors
Woodline Partners
Morgan Stanley
FMR
Geode Capital Management
Adage Capital Partners GP
Goldman Sachs Group
Jupiter Asset Management
Schonfeld Strategic Advisors

View all funds holding Arcturus Therapeutics Hldg I